In addition, MiD49 expression is significantly lower in the pancreatic tumor tissues compared to the adjacent non-tumor tissues, and PDAC patients with a low expression level of MiD49 have clearly poorer overall survival than those with high MiD49. This evidence concerns the gene MIEF2 and neoplasm.